U.S., Oct. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07880886) titled 'Goflikicept for Resolution and Prevention of Attacks in Pediatric and Adolescent Patients With Colchicine-Resistant or Colchicine-Intolerant Familial Mediterranean Fever' on Oct. 12.
Brief Summary: The primary objective is to evaluate the main pharmacokinetic (PK) parameters, efficacy, and safety of goflikicept (GFC) in children and adolescents with colchicine-resistant or colchicine-intolerant familial Mediterranean fever (FMF).
Study Start Date: Dec., 2026
Study Type: INTERVENTIONAL
Condition:
Familial Mediterranean Fever
FMF
Intervention:
BIOLOGICAL: RPH-104
solution for subcutaneous administration 40 mg/mL, 2 mL in the 4-...